| scholarly article | Q13442814 |
| P2093 | author name string | Basta M | |
| Frank MM | |||
| Fries LF | |||
| Kirshbom P | |||
| P2860 | cites work | The binding of complement component C3 to antibody-antigen aggregates after activation of the alternative pathway in human serum | Q42154683 |
| High-dose intravenous immunoglobulin modifies complement-mediated in vivo clearance | Q44905960 | ||
| Complement-mediated tissue damage: contribution of the classical and alternate complement pathways in the Forssman reaction | Q46899767 | ||
| The Relative Efficacies of 7S and 19S Forssman Antibody in Producing Lesions in the Guinea Pig | Q54037256 | ||
| The Treatment of Kawasaki Syndrome with Intravenous Gamma Globulin | Q58478448 | ||
| Generation of low m.w., C3-bearing immunoglobulin in human serum | Q70987006 | ||
| Interaction of C3 and C3b with immunoglobulin G | Q71048499 | ||
| Immunopharmacological approach to Forssman shock | Q71309662 | ||
| Large scale isolation of functionally active components of the human complement system | Q71542480 | ||
| A study of the cellular distribution of Forssman antigen in various species | Q74255875 | ||
| Intravenous immunoglobulins as therapeutic agents | Q33449825 | ||
| Intravenous and standard immune serum globulin preparations interfere with uptake of 125I-C3 onto sensitized erythrocytes and inhibit hemolytic complement activity | Q33459986 | ||
| High-dose intravenous gammaglobulin for idiopathic thrombocytopenic purpura in childhood | Q33475647 | ||
| Immunoglobulin M antibodies present in the acute phase of Kawasaki syndrome lyse cultured vascular endothelial cells stimulated by gamma interferon | Q34577395 | ||
| Heterophile antibodies and tissue injury. 3. A role for platelets in the development of lethal vascular injury during Forssman shock in guinea pigs | Q35864567 | ||
| C3b covalently bound to IgG demonstrates a reduced rate of inactivation by factors H and I | Q36349666 | ||
| Classical complement pathway activation by antipneumococcal antibodies leads to covalent binding of C3b to antibody molecules | Q37102226 | ||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | pig | Q787 |
| P304 | page(s) | 1974-1981 | |
| P577 | publication date | 1989-12-01 | |
| P1433 | published in | Journal of Clinical Investigation | Q3186904 |
| P1476 | title | Mechanism of therapeutic effect of high-dose intravenous immunoglobulin. Attenuation of acute, complement-dependent immune damage in a guinea pig model | |
| P478 | volume | 84 |
| Q38820352 | 10% liquid human immunoglobulin (KIOVIG(®)) for immunomodulation in autoimmune disorders |
| Q34580488 | A Single Intravenous Infusion of Gamma Globulin as Compared with Four Infusions in the Treatment of Acute Kawasaki Syndrome |
| Q40790004 | Adverse effects of intravenous immunoglobulin |
| Q36602804 | Adverse effects of treatment with intravenous immunoglobulins for neurological diseases |
| Q36030537 | Age-related changes in the hepatic microcirculation in mice |
| Q71037753 | Animal models for complement deficiencies |
| Q72769499 | Anti-idiotypic activity against anti-myeloperoxidase antibodies in pooled human immunoglobulin |
| Q36359683 | Anti-inflammatory effect of intravenous immunoglobulin mediated through modulation of complement activation |
| Q34667057 | Antibodies in transplantation |
| Q71834117 | Beneficial effects of systemic immunoglobulin in experimental membranous nephropathy |
| Q33364381 | Can antibodies with specificity for soluble antigens mimic the therapeutic effects of intravenous IgG in the treatment of autoimmune disease? |
| Q35937151 | Dermatomyositis Developing in the first Trimester of Pregnancy |
| Q77819952 | Effect of intravenous immunoglobulin therapy on plasma complement |
| Q46793483 | Efficacy of high-dose intravenous immunoglobulin therapy in Japanese patients with steroid-resistant polymyositis and dermatomyositis |
| Q71457783 | Efficacy of intravenous immunoglobulin therapy in a case of juvenile dermatomyositis |
| Q40667159 | F(ab)'2-mediated neutralization of C3a and C5a anaphylatoxins: a novel effector function of immunoglobulins |
| Q88500050 | GM-CSF and IL-4 are not involved in IVIG-mediated amelioration of ITP in mice: a role for IL-11 cannot be ruled out |
| Q34155637 | High-dose intravenous immunoglobulin exerts its beneficial effect in patients with dermatomyositis by blocking endomysial deposition of activated complement fragments |
| Q87216501 | High-dose intravenous immunoglobulin exerts neuroprotective effect in the rat model of neonatal asphyxia |
| Q39579621 | Hyperferritinemia as indicator for intravenous immunoglobulin treatment in reactive macrophage activation syndromes |
| Q35161081 | IVIG--mechanisms of action. |
| Q37062115 | IVIg attenuates complement and improves spinal cord injury outcomes in mice. |
| Q72920759 | IgG inhibits the increase of platelet-associated C3 stimulated by anti-platelet antibodies |
| Q38346227 | IgM-enriched human introvenous immunoglobulin strongly inhibits complement-dependent porcine cell cytotoxicity mediated by human xenoreactive antibodies. |
| Q47712347 | Immune complex-like moieties in immunoglobulin for intravenous use (i.v.Ig) bind complement and enhance phagocytosis of human erythrocytes |
| Q34242612 | Immunoglobulin in the control of complement action |
| Q35766497 | Immunoglobulin prevents complement-mediated hyperacute rejection in swine-to-primate xenotransplantation |
| Q33596381 | Immunomodulating effects of intravenous immunoglobulin in autoimmune and inflammatory diseases |
| Q41663188 | In vitro effects of polyvalent immunoglobulin for intravenous use. |
| Q37877259 | Indications and safety of intravenous and subcutaneous immunoglobulin therapy |
| Q41822812 | Interaction of C3b(2)--IgG complexes with complement proteins properdin, factor B and factor H: implications for amplification |
| Q35795157 | Interaction of antibody with Forssman antigen in guinea pigs. A mechanism of adaptation to antibody- and complement-mediated injury |
| Q40673466 | Intravenous immune globulin in recurrent abortion. |
| Q73968578 | Intravenous immunoglobulin (IVIG) attenuates antibody binding in acute haemorrhagic immunopneumonitis in a rat model of complement-dependent lung injury |
| Q37487547 | Intravenous immunoglobulin protects neurons against amyloid beta-peptide toxicity and ischemic stroke by attenuating multiple cell death pathways |
| Q48150515 | Intravenous immunoglobulin therapy in acute disseminated encephalomyelitis |
| Q33405903 | Intravenous immunoglobulin therapy: how does IgG modulate the immune system? |
| Q34124893 | Intravenous immunoglobulin treatment of experimental T cell-mediated autoimmune disease. Upregulation of T cell proliferation and downregulation of tumor necrosis factor alpha secretion |
| Q37433060 | Intravenous immunoglobulins (IVIg) in the treatment of autoimmune diseases |
| Q37626118 | Intravenous immunoglobulins--understanding properties and mechanisms |
| Q41589724 | Modulation of autoimmune responses by intravenous immunoglobulin (IVIg). |
| Q33339749 | New aspects in the pathogenesis and treatment of thrombotic thrombocytopenic purpura and hemolytic uremic syndrome |
| Q53965658 | Open trial of intravenous immune serum globulin for chronic sinusitis in children. |
| Q38372972 | Prophylactic treatment with sulphonated immunoglobulin G attenuates development of mechanical allodynia-like response in mice with neuropathic pain |
| Q34447342 | Recent advances in the immunology of xenotransplantation |
| Q57723250 | Selective induction of interleukin-1 receptor antagonist and interleukin-8 in human monocytes by normal polyspecific IgG (intravenous immunoglobulin) |
| Q58393545 | Self-reactive antibodies (natural autoantibodies) in healthy individuals |
| Q73501031 | The covalent interaction of C3 with IgG immune complexes |
| Q36731972 | The effects of intravenous immune globulin on complement-dependent immune damage of cells and tissues |
| Q41101079 | The growth arresting effect of human immunoglobulin for intravenous use is mediated by antibodies recognizing membrane glycolipids |
| Q41170285 | Therapeutic Potential of Intravenous Immunoglobulin in Acute Brain Injury |
| Q39729881 | Therapeutic effect of IVIG on inflammatory arthritis in mice is dependent on the Fc portion and independent of sialylation or basophils. |
| Q37622947 | Vascular involvement in the pathogenesis of idiopathic inflammatory myopathies |
| Q73085297 | [Immunomodulatory effects of intravenous immunoglobulins in autoimmune diseases] |
| Q80953233 | [Immunomodulatory effects of intravenous immunoglobulins] |
Search more.